Edwards Lifesciences
657 hedge funds and large institutions have $15.9B invested in Edwards Lifesciences in 2016 Q1 according to their latest regulatory filings, with 102 funds opening new positions, 220 increasing their positions, 242 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 16 → 16 (0)
9% less repeat investments, than reductions
Existing positions increased: 220 | Existing positions reduced: 242
6% less capital invested
Capital invested by funds: $16.9B → $15.9B (-$1.06B)
Holders
657
Holding in Top 10
16
Calls
$175M
Puts
$115M
Top Buyers
1 | +$261M | |
2 | +$204M | |
3 | +$104M | |
4 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
+$77.7M |
5 |
Citadel Advisors
Miami,
Florida
|
+$72.9M |
Top Sellers
1 | -$2.46B | |
2 | -$369M | |
3 | -$107M | |
4 |
Winslow Capital Management
Minneapolis,
Minnesota
|
-$97.2M |
5 |
Capital Research Global Investors
Los Angeles,
California
|
-$92.7M |